Our company is currently establishing a groundbreaking collaborative framework with leading domestic research institutions. One example of this is our deepening partnership with the Institute for Quantitative Biosciences at the University of Tokyo (hereafter referred to as IQB). Together with IQB, we are co-developing, implementing, and evolving our proprietary security system, the “IQB Gate”. This system integrates security functions with vital sign measurement capabilities and is adaptable to both centralized management and decentralized independent management, making it suitable for various installation environments.
We began with basic research grounded in life sciences and have accumulated a wealth of experience in researching unique technologies over many years. The “IQB Gate” is one such outcome of these efforts, excelling in both design and functionality.
Even before the COVID-19 pandemic, we have been individually advancing various elemental technologies, including biometric recognition technology, motion detection and tracking technology, advanced encryption security technology, edge computing technology, multi-architecture adaptation, vital signs measurement technology, and biomarker measurement technology. We have realized that the synergy of these technologies can generate high added value, a fact recognized by leading domestic research and medical institutions, including the Institute for Quantitative Biosciences.
We would like to take this opportunity to extend our sincere gratitude to all related parties for their considerable support and cooperation in the evolution of the IQB Gate.
Looking ahead, we plan to strategically deploy joint research equipment on university campuses with top-tier research standards both domestically and internationally, and to introduce innovative collaborative demonstration research tools. Through these initiatives, our company aims to continue accumulating cutting-edge research and to pioneer new horizons in future technologies.